Andere talen BioNexus Gene Lab Corp.

Aandelen

BGLC

US0906282076

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,5949 ^USD	-1,51%		-0,85%	+12,25%

16/04	BioNexus Gene Lab Corp. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
29/02	BioNexus Gene Lab Corp. Verstrekt informatie aan aandeelhouders	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	18/04
BioNexus Gene Lab : Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Form 8-K	18/04
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
BioNexus Gene Lab : Submission of Matters to a Vote of Security Holders - Form 8-K	01/04
BioNexus Gene Lab Corp. Provides Information to Shareholders	29/02
Certain Common Stock of BioNexus Gene Lab Corp. are subject to a Lock-Up Agreement Ending on 18-JAN-2024.	18/01
Soo Kow Lai Provides Information to Shareholders of BioNexus Gene Lab Corp	17/01
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Bionexus Gene Lab Corp. Announces Resignation of Wei Li Leong as Chief Financial Officer	03/11
BioNexus Gene Lab Names Chi Yuen Leong as CEO	16-10-23
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as the Chief Executive Officer	16-10-23
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as A Director	16-10-23
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Chief Executive Officer	11-10-23
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Board of Directors	11-10-23
BioNexus Gene Lab Corp. Announces Executive Changes	07-09-23
Top Premarket Gainers	23-08-23
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	16-08-23
BioNexus Gene Lab Raises $5.8 Million from Public Share Offering	24-07-23
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market	24-07-23
BioNexus Gene Lab Corp.(NasdaqCM:BGLC) added to NASDAQ Composite Index	24-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BioNexus Gene Lab Corp.

Aandelen

BGLC

US0906282076

Andere talen

Filters